Prediction of breast cancer metastasis by genomic profiling: Where do we stand?

Clinical and Experimental Metastasis

Volumn 26, Issue 6, 2009, Pages 547-558

  Pfeffer, Ulrich ^a   Romeo, Francesco ^a   Noonan, Douglas M ^b,c   Albini, Adriana ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b IRCCS MULTIMEDICA   (Italy)

^c UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Angiogenesis; Breast cancer; Gene expression profiling; Metastasis; Stroma

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; MICRORNA;

ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; DIAGNOSTIC VALUE; DNA FINGERPRINTING; EARLY DIAGNOSIS; GENE EXPRESSION REGULATION; GENE MUTATION; HUMAN; METASTASIS; METASTASIS POTENTIAL; MOLECULAR BIOLOGY; PREDICTION; PROGNOSIS;

BREAST NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MICRORNAS; NEOPLASM METASTASIS;

EID: 68049120432     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-009-9254-y     Document Type: Article

References (77)

1. D Hanahan RA Weinberg 2000 The hallmarks of cancer Cell 100 1 57 70 10.1016/S0092-8674(00)81683-9
2. IJ Fidler ML Kripke 1977 Metastasis results from preexisting variant cells within a malignant tumor Science 197 4306 893 895 10.1126/science.887927
3. ER Fearon SR Hamilton B Vogelstein 1987 Clonal analysis of human colorectal tumors Science 238 4824 193 197 10.1126/science.2889267
4. PC Nowell 1976 The clonal evolution of tumor cell populations Science 194 4260 23 28 10.1126/science.959840
5. B Vogelstein ER Fearon SE Kern 1989 Allelotype of colorectal carcinomas Science 244 4901 207 211 10.1126/science.2565047
6. IJ Fidler 1990 Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture Cancer Res 50 19 6130 6138
7. IJ Fidler ML Kripke 2003 Genomic analysis of primary tumors does not address the prevalence of metastatic cells in the population Nat Genet 34 1 23 10.1038/ng0503-23a (author reply 5)
8. R Bernards RA Weinberg 2002 A progression puzzle Nature 418 6900 823 10.1038/418823a (Pubitemid 34966286)
9. RA Gatenby P Maini 2002 Modelling a new angle on understanding cancer Nature 420 6915 462 10.1038/420462b
10. PA Edwards 2002 Metastasis: the role of chance in malignancy Nature 419 6907 559 560 10.1038/419559b (author reply 60)
11. A Player JC Barrett ES Kawasaki 2004 Laser capture microdissection, microarrays and the precise definition of a cancer cell Expert Rev Mol Diagn 4 6 831 840 10.1586/14737159.4.6.831 (Pubitemid 39487587)
12. RR Langley IJ Fidler 2007 Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis Endocr Rev 28 3 297 321 10.1210/er.2006-0027 (Pubitemid 46984829)
13. IJ Fidler 2002 The organ microenvironment and cancer metastasis Differentiation 70 9-10 498 505 10.1046/j.1432-0436.2002.700904.x (Pubitemid 36194315)
14. IJ Fidler 2001 Seed and soil revisited: contribution of the organ microenvironment to cancer metastasis Surg Oncol Clin N Am 10 2 257 269 (vii-viiii)
15. A Albini MB Sporn 2007 The tumour microenvironment as a target for chemoprevention Nat Rev Cancer 7 2 139 147 10.1038/nrc2067
16. LA Liotta EC Kohn 2001 The microenvironment of the tumour-host interface Nature 411 6835 375 379 10.1038/35077241 (Pubitemid 32467047)
17. JP Sleeman N Cremers 2007 New concepts in breast cancer metastasis: tumor initiating cells and the microenvironment Clin Exp Metastasis 24 8 707 715 10.1007/s10585-007-9122-6 (Pubitemid 50000183)
18. S Ramaswamy KN Ross ES Lander 2003 A molecular signature of metastasis in primary solid tumors Nat Genet 33 1 49 54 10.1038/ng1060 (Pubitemid 36068681)
19. A Albini V Mirisola U Pfeffer 2008 Metastasis signatures: genes regulating tumor-microenvironment interactions predict metastatic behavior Cancer Metastasis Rev 27 1 75 83 10.1007/s10555-007-9111-x
20. A Patocs L Zhang Y Xu 2007 Breast-cancer stromal cells with TP53 mutations and nodal metastases N Engl J Med 357 25 2543 2551 10.1056/NEJMoa071825 (Pubitemid 350294221)
21. JJ Chen RR Delongchamp CA Tsai 2004 Analysis of variance components in gene expression data Bioinformatics (Oxford, England) 20 9 1436 1446 10.1093/bioinformatics/bth118 (Pubitemid 38931413)
22. BH Mecham GT Klus J Strovel 2004 Sequence-matched probes produce increased cross-platform consistency and more reproducible biological results in microarray-based gene expression measurements Nucleic Acids Res 32 9 e74 10.1093/nar/gnh071
23. K Kapur Y Xing Z Ouyang 2007 Exon arrays provide accurate assessments of gene expression Genome Biol 8 5 R82 10.1186/gb-2007-8-5-r82 (Pubitemid 351895145)
24. WF Symmans M Ayers EA Clark 2003 Total RNA yield and microarray gene expression profiles from fine-needle aspiration biopsy and core-needle biopsy samples of breast carcinoma Cancer 97 12 2960 2971 10.1002/cncr.11435 (Pubitemid 36676249)
25. C Sotiriou TJ Powles M Dowsett 2002 Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer Breast Cancer Res 4 3 R3 10.1186/bcr433
26. L Pusztai M Ayers J Stec 2003 Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors Clin Cancer Res 9 7 2406 2415
27. GL Mutter D Zahrieh C Liu 2004 Comparison of frozen and RNALater solid tissue storage methods for use in RNA expression microarrays BMC Genomics 5 1 88 10.1186/1471-2164-5-88 (Pubitemid 39546637)
28. T Goldmann AM Flohr H Murua Escobar 2004 The HOPE-technique permits Northern blot and microarray analyses in paraffin-embedded tissues Pathol Res Pract 200 7-8 511 515 10.1016/j.prp.2004.04.008 (Pubitemid 39655047)
29. CM Perou T Sorlie MB Eisen 2000 Molecular portraits of human breast tumours Nature 406 6797 747 752 10.1038/35021093 (Pubitemid 30671230)
30. B Weigelt Z Hu X He 2005 Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer Cancer Res 65 20 9155 9158 10.1158/0008-5472.CAN-05-2553 (Pubitemid 41507977)
31. B Weigelt AM Glas LF Wessels 2003 Gene expression profiles of primary breast tumors maintained in distant metastases Proc Natl Acad Sci USA 100 26 15901 15905 10.1073/pnas.2634067100 (Pubitemid 38021087)
32. Y Feng B Sun X Li 2007 Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients Breast Cancer Res Treat 103 3 319 329 10.1007/s10549-006-9385-7 (Pubitemid 46944516)
33. M Vecchi P Nuciforo S Romagnoli 2007 Gene expression analysis of early and advanced gastric cancers Oncogene 26 29 4284 4294 10.1038/sj.onc.1210208 (Pubitemid 46975798)
34. T Sorlie CM Perou R Tibshirani 2001 Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA 98 19 10869 10874 10.1073/pnas.191367098 (Pubitemid 32878711)
35. S Gruvberger M Ringner Y Chen 2001 Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns Cancer Res 61 16 5979 5984
36. C Sotiriou SY Neo LM McShane 2003 Breast cancer classification and prognosis based on gene expression profiles from a population-based study Proc Natl Acad Sci USA 100 18 10393 10398 10.1073/pnas.1732912100 (Pubitemid 37071889)
37. Z Hu C Fan DS Oh 2006 The molecular portraits of breast tumors are conserved across microarray platforms BMC Genomics 7 96 10.1186/1471-2164-7-96 (Pubitemid 43786485)
38. AV Kapp R Tibshirani 2007 Are clusters found in one dataset present in another dataset? Biostatistics (Oxford, England) 8 1 9 31 10.1093/biostatistics/ kxj029 (Pubitemid 44906101)
39. AV Kapp SS Jeffrey A Langerod 2006 Discovery and validation of breast cancer subtypes BMC Genomics 7 231 10.1186/1471-2164-7-231 (Pubitemid 44468829)
40. I Vanden Bempt M Drijkoningen C De Wolf-Peeters 2007 The complexity of genotypic alterations underlying HER2-positive breast cancer: an explanation for its clinical heterogeneity Curr Opin Oncol 19 6 552 557
41. S Menard SM Pupa M Campiglio 2003 Biologic and therapeutic role of HER2 in cancer Oncogene 22 42 6570 6578 10.1038/sj.onc.1206779
42. AL Richardson ZC Wang A De Nicolo 2006 X chromosomal abnormalities in basal-like human breast cancer Cancer Cell 9 2 121 132 10.1016/j.ccr.2006.01.013 (Pubitemid 43202662)
43. I Hedenfalk D Duggan Y Chen 2001 Gene-expression profiles in hereditary breast cancer N Engl J Med 344 8 539 548 10.1056/NEJM200102223440801 (Pubitemid 32167867)
44. C Fan DS Oh L Wessels 2006 Concordance among gene-expression-based predictors for breast cancer N Engl J Med 355 6 560 569 10.1056/NEJMoa052933 (Pubitemid 44200649)
45. L Perreard C Fan JF Quackenbush 2006 Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay Breast Cancer Res 8 2 R23 10.1186/bcr1399 (Pubitemid 44377908)
46. PB Gupta C Kuperwasser JP Brunet 2005 The melanocyte differentiation program predisposes to metastasis after neoplastic transformation Nat Genet 37 10 1047 1054 10.1038/ng1634 (Pubitemid 41486656)
47. A Dupuy RM Simon 2007 Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting J Natl Cancer Inst 99 2 147 157 10.1093/jnci/djk018
48. DH Roukos E Briasoulis 2007 Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome Nat Clin Pract Oncol 4 10 578 590 10.1038/ncponc0930 (Pubitemid 47534757)
49. LD Miller ET Liu 2007 Expression genomics in breast cancer research: microarrays at the crossroads of biology and medicine Breast Cancer Res 9 2 206 10.1186/bcr1662
50. PE Lonning T Sorlie AL Borresen-Dale 2005 Genomics in breast cancer-therapeutic implications Nat Clin Pract Oncol 2 1 26 33 10.1038/ncponc0072 (Pubitemid 40823178)
51. PE Lonning S Knappskog V Staalesen 2007 Breast cancer prognostication and prediction in the postgenomic era Ann Oncol 18 8 1293 1306 10.1093/annonc/ mdm013 (Pubitemid 47305001)
52. K Driouch T Landemaine S Sin 2007 Gene arrays for diagnosis, prognosis and treatment of breast cancer metastasis Clin Exp Metastasis 24 8 575 585 10.1007/s10585-007-9110-x (Pubitemid 50000498)
53. JD Brenton LA Carey AA Ahmed 2005 Molecular classification and molecular forecasting of breast cancer: ready for clinical application? J Clin Oncol 23 29 7350 7360 10.1200/JCO.2005.03.3845 (Pubitemid 46202348)
54. K Rennstam I Hedenfalk 2006 High-throughput genomic technology in research and clinical management of breast cancer. Molecular signatures of progression from benign epithelium to metastatic breast cancer Breast Cancer Res 8 4 213 10.1186/bcr1528 (Pubitemid 46442932)
55. MC Cheang M van de Rijn TO Nielsen 2008 Gene expression profiling of breast cancer Annu Rev Pathol 3 67 97 10.1146/annurev.pathmechdis.3.121806. 151505
56. S Paik S Shak G Tang 2004 A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer N Engl J Med 351 27 2817 2826 10.1056/NEJMoa041588 (Pubitemid 40051905)
57. JA Sparano S Paik 2008 Development of the 21-gene assay and its application in clinical practice and clinical trials J Clin Oncol 26 5 721 728 10.1200/JCO.2007.15.1068 (Pubitemid 351264384)
58. LJ van't Veer H Dai MJ van de Vijver 2002 Gene expression profiling predicts clinical outcome of breast cancer Nature 415 6871 530 536 10.1038/415530a (Pubitemid 34130608)
59. MJ van de Vijver YD He LJ van't Veer 2002 A gene-expression signature as a predictor of survival in breast cancer N Engl J Med 347 25 1999 2009 10.1056/NEJMoa021967 (Pubitemid 35461656)
60. P Eden C Ritz C Rose 2004 "Good Old" clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers Eur J Cancer 40 12 1837 1841 10.1016/j.ejca.2004.02.025 (Pubitemid 39036757)
61. F Cardoso L Van't Veer E Rutgers 2008 Clinical application of the 70-gene profile: the MINDACT trial J Clin Oncol 26 5 729 735 10.1200/JCO.2007.14.3222 (Pubitemid 351264385)
62. JA Foekens D Atkins Y Zhang 2006 Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer J Clin Oncol 24 11 1665 1671 10.1200/JCO.2005.03.9115 (Pubitemid 46622137)
63. HY Chang DS Nuyten JB Sneddon 2005 Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival Proc Natl Acad Sci USA 102 10 3738 3743 10.1073/pnas.0409462102 (Pubitemid 40354681)
64. R Liu X Wang GY Chen 2007 The prognostic role of a gene signature from tumorigenic breast-cancer cells N Engl J Med 356 3 217 226 10.1056/NEJMoa063994 (Pubitemid 46143225)
65. S Loi B Haibe-Kains C Desmedt 2007 Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade J Clin Oncol 25 10 1239 1246 10.1200/JCO.2006.07.1522 (Pubitemid 46640570)
66. JS Ross C Hatzis WF Symmans 2008 Commercialized multigene predictors of clinical outcome for breast cancer Oncol 13 5 477 493 10.1634/theoncologist. 2007-0248 (Pubitemid 351872866)
67. L Ein-Dor I Kela G Getz 2005 Outcome signature genes in breast cancer: is there a unique set? Bioinformatics (Oxford, England) 21 2 171 178 10.1093/bioinformatics/bth469 (Pubitemid 40202018)
68. L Ein-Dor O Zuk E Domany 2006 Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer Proc Natl Acad Sci USA 103 15 5923 5928 10.1073/pnas.0601231103
69. Y Pawitan J Bjohle L Amler 2005 Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts Breast Cancer Res 7 6 R953 R964 10.1186/bcr1325
70. J Day-Richter MA Harris M Haendel 2007 OBO-Edit an ontology editor for biologists Bioinformatics (Oxford, England) 23 16 2198 2200 10.1093/ bioinformatics/btm112 (Pubitemid 47394127)
71. VG Tusher R Tibshirani G Chu 2001 Significance analysis of microarrays applied to the ionizing radiation response Proc Natl Acad Sci USA 98 9 5116 5121 10.1073/pnas.091062498 (Pubitemid 32397092)
72. AJ Minn GP Gupta PM Siegel 2005 Genes that mediate breast cancer metastasis to lung Nature 436 7050 518 524 10.1038/nature03799 (Pubitemid 41112921)
73. CR Acharya DS Hsu CK Anders 2008 Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer J Am Med Assoc 299 13 1574 1587 10.1001/jama.299.13.1574
74. GA Calin CM Croce 2006 MicroRNA signatures in human cancers Nat Rev Cancer 6 11 857 866 10.1038/nrc1997 (Pubitemid 44629897)
75. AJ Lowery N Miller RE McNeill 2008 MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management Clin Cancer Res 14 2 360 365 10.1158/1078-0432.CCR-07-0992 (Pubitemid 351226101)
76. C Blenkiron LD Goldstein NP Thorne 2007 MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype Genome Biol 8 10 R214 10.1186/gb-2007-8-10-r214 (Pubitemid 351917463)
77. P Kapranov J Cheng S Dike 2007 RNA maps reveal new RNA classes and a possible function for pervasive transcription Science 316 5830 1484 1488 10.1126/science.1138341 (Pubitemid 46906616)